If you've spent any time in chronic illness spaces lately, you've probably started seeing the word "peptides" pop up more and more. And if you follow anything related to GLP-1 medications — the class that includes Ozempic and Wegovy — you may have noticed that researchers are suddenly very interested in what these drugs do beyond weight loss. This isn't just wellness trend noise. There's real, published research happening right now that the chronic illness community needs to